Transient Insomnia Clinical Trial
Official title:
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Crossover Study of Single Doses of LY2624803 in a 5-hour Phase Advance Model of Transient Insomnia in Healthy Subjects
The aim of this study is to learn how different doses of LY2624803 affect sleep in healthy people. The study has four treatment periods. Participants will receive a single dose of LY2624803, another sleeping pill, or placebo in each treatment period. The study will last approximately 1 month for each participant.
n/a
Allocation: Randomized, Endpoint Classification: Pharmacodynamics Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator)
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03331042 -
SM-1 vs 2 Comparators and Placebo in Participants With a History of Transient Insomnia.
|
Phase 3 | |
Completed |
NCT00594022 -
Evaluation of Vestibular Stimulation to Help Occasional Sleeplessness
|
N/A | |
Completed |
NCT00163046 -
A 28-Day Polysomnographic Study of Gabapentin in Transient Insomnia Induced by a Sleep Phase Advance
|
Phase 3 | |
Completed |
NCT00667108 -
A Study of Single-Dose Gabapentin in Transient Insomnia Induced by a Sleep Phase Advance
|
Phase 3 | |
Completed |
NCT00666939 -
A Study of Single-Dose Gabapentin in Subjects With Transient Insomnia Induced by a Sleep Phase Advance
|
Phase 3 | |
Completed |
NCT00666770 -
A Polysomnographic Study of Single-Dose Gabapentin in Transient Insomnia Induced by a Sleep Phase Advance
|
Phase 3 | |
Recruiting |
NCT05457790 -
Feasibility and Preliminary Efficacy of Acceptance and Commitment Therapy (ACT) for Sleep Disturbances in Adults With Sickle Cell Disease (SCD)
|
N/A | |
Not yet recruiting |
NCT04396327 -
SM-1 vs. an Active Comparator in A Model of Transient Insomnia
|
Phase 2 | |
Withdrawn |
NCT03338764 -
An Investigational Study to Assess Efficacy and Pattern of Use of SM-1 in Subjects With a History of Transient Insomnia
|
Phase 3 | |
Completed |
NCT00674752 -
A Polysomnographic Study Of Single-Dose Gabapentin In Transient Insomnia
|
Phase 3 | |
Completed |
NCT00666575 -
A Study of the Safety of Gabapentin in a Potential Over-the-Counter Population With Occasional Sleeplessness
|
Phase 3 | |
Completed |
NCT00671398 -
Efficacy of Ramelteon on Transient Insomnia in Healthy Adults
|
Phase 3 | |
Completed |
NCT00659100 -
A Trial to Assess Consumer Self-Selection and Use of Gabapentin for Occasional Sleeplessness in an Over-the-Counter Environment
|
Phase 3 |